why choose us

First received: July 03, 2024

Clinical Trial: Ketamine for Methamphetamine Use Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Substance Use Disorders
Substance Use
Methamphetamine Abuse

Study Type: INTERVENTIONAL


Official Title: NIDA CTN-0132 Randomized, Double-Blind, Active Placebo-Controlled Trial of Ketamine for Methamphetamine Use Disorder (KMD)

Brief Summary: This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD.The study design is a 12-week randomized, double-blind, controlled trial comparing intravenous (IV) ketamine against IV midazolam, delivered over six weeks in 120 adults with moderate to severe methamphetamine use disorder (MUD).

Read more